Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
| $52.9M | 0.12% |
1,909,800
-1,124,800
| -37% | -$36M |
|
|
GRFS
152
Grifois
GRFS
$5.44B
| $52.5M | 0.12% |
2,605,931
-1,641,545
| -39% | -$36.8M |
|
153
PUT
Verizon
VZ
$201B
| $52.2M | 0.12% |
971,200
-442,700
| -31% | -$25.3M |
|
154
PUT
Morgan Stanley
MS
$333B
| $52M | 0.12% |
1,530,200
-1,884,800
| -55% | -$88.8M |
|
155
Clorox
CLX
$12.1B
| $51.8M | 0.12% |
298,893
+285,945
| +2,208% | +$47.2M |
|
156
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $51.3M | 0.12% |
1,501,600
+436,200
| +41% | +$17.9M |
|
157
Applied Materials
AMAT
$378B
| $51.1M | 0.11% |
1,115,779
-592,216
| -35% | -$34M |
|
|
ADSW
158
DELISTED
Advanced Disposal Services Inc
ADSW
| $50.9M | 0.11% |
1,550,764
+840,879
| +118% | +$27.6M |
|
159
Humana
HUM
$46.7B
| $50.3M | 0.11% |
160,286
-19,446
| -11% | -$6.56M |
|
160
PUT
Boeing
BA
$175B
| $50M | 0.11% |
335,200
+130,000
| +63% | +$35.6M |
|
161
CALL
Visa
V
$697B
| $49.9M | 0.11% |
309,400
+56,000
| +22% | +$10.5M |
|
|
162
iShares MSCI Emerging Markets ETF
EEM
$28B
| $49.8M | 0.11% |
1,459,623
+21,776
| +2% | +$893K |
|
163
PUT
iShares MSCI Brazil ETF
EWZ
$9.13B
| $49.4M | 0.11% |
2,095,400
-123,300
| -6% | -$4.76M |
|
164
Louisiana-Pacific
LPX
$5.35B
| $48.6M | 0.11% |
2,828,616
-329,956
| -10% | -$9.13M |
|
165
Yum! Brands
YUM
$41.4B
| $48.3M | 0.11% |
704,697
+230,723
| +49% | +$21.5M |
|
166
CALL
iShares Biotechnology ETF
IBB
$9.55B
| $47.8M | 0.11% |
444,000
+184,000
| +71% | +$21.2M |
|
167
CALL
AT&T
T
$169B
| $47.5M | 0.11% |
2,157,326
+1,808,452
| +518% | +$49.4M |
|
168
Johnson & Johnson
JNJ
$643B
| $47.5M | 0.11% |
361,943
-748,541
| -67% | -$106M |
|
169
Williams Companies
WMB
$85.8B
| $47.3M | 0.11% |
3,339,930
-3,232,374
| -49% | -$62.6M |
|
|
MLNX
170
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $47M | 0.11% |
387,200
+212,400
| +122% | +$25M |
|
|
XYZ
171
Block Inc
XYZ
$49.5B
| $46.9M | 0.11% |
896,096
+316,490
| +55% | +$21.6M |
|
172
PUT
Starbucks
SBUX
$118B
| $45.7M | 0.1% |
695,800
-757,100
| -52% | -$61.2M |
|
173
Regeneron Pharmaceuticals
REGN
$72.9B
| $45.6M | 0.1% |
93,380
-5,426
| -5% | -$2.24M |
|
174
CALL
Gilead Sciences
GILD
$167B
| $45.5M | 0.1% |
608,800
-174,500
| -22% | -$12.1M |
|
|
BMY.RT
175
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $45.5M | 0.1% |
11,973,064
-4,073,886
| -25% | -$13.4M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.